statistiche ricercatore

PEGHIN, MADDALENA

Distribuzione geografica

Continente	#
EU - Europa	3.512
NA - Nord America	3.307
AS - Asia	2.314
SA - Sud America	303
AF - Africa	44
Continente sconosciuto - Info sul continente non disponibili	5
OC - Oceania	3
Totale	9.488

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	3.225
IT - Italia	2.333
SG - Singapore	1.018
CN - Cina	486
HK - Hong Kong	365
BR - Brasile	252
IE - Irlanda	245
GB - Regno Unito	196
VN - Vietnam	194
SE - Svezia	147
FR - Francia	126
RU - Federazione Russa	118
FI - Finlandia	108
IN - India	81
DE - Germania	79
CA - Canada	41
JP - Giappone	39
MX - Messico	37
NL - Olanda	35
BD - Bangladesh	32
ES - Italia	26
AT - Austria	25
IQ - Iraq	22
UA - Ucraina	21
AR - Argentina	18
PL - Polonia	18
TR - Turchia	17
CZ - Repubblica Ceca	15
NG - Nigeria	10
ZA - Sudafrica	10
CO - Colombia	8
EC - Ecuador	8
EG - Egitto	8
VE - Venezuela	8
SY - Repubblica araba siriana	7
AE - Emirati Arabi Uniti	6
PK - Pakistan	6
SA - Arabia Saudita	6
UZ - Uzbekistan	6
JO - Giordania	5
LT - Lituania	5
CH - Svizzera	4
DZ - Algeria	4
EU - Europa	4
ID - Indonesia	4
MA - Marocco	4
PH - Filippine	4
AU - Australia	3
AZ - Azerbaigian	3
KG - Kirghizistan	3
PY - Paraguay	3
AL - Albania	2
BG - Bulgaria	2
CL - Cile	2
KE - Kenya	2
NP - Nepal	2
PE - Perù	2
UG - Uganda	2
UY - Uruguay	2
AM - Armenia	1
AO - Angola	1
BB - Barbados	1
BE - Belgio	1
BH - Bahrain	1
DK - Danimarca	1
ET - Etiopia	1
GA - Gabon	1
GR - Grecia	1
HN - Honduras	1
HU - Ungheria	1
KH - Cambogia	1
KR - Corea	1
LB - Libano	1
LU - Lussemburgo	1
MY - Malesia	1
OM - Oman	1
PA - Panama	1
PR - Porto Rico	1
PT - Portogallo	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	9.488

Salva come PNG Salva come JPEG

Città	#
Milan	1.682
San Jose	610
Singapore	547
Ashburn	464
Dallas	384
Hong Kong	358
Dublin	244
Beijing	153
Chicago	152
The Dalles	152
Rome	141
Boardman	116
Nyköping	114
Lauterbourg	106
Chandler	101
Princeton	96
London	95
Helsinki	93
Council Bluffs	82
Ho Chi Minh City	82
Los Angeles	68
Washington	60
New York	47
Hanoi	39
Fairfield	38
Tokyo	38
Santa Clara	35
Orem	32
São Paulo	29
Pune	27
Seattle	26
Ogden	24
Guangzhou	22
Chennai	20
Mexico City	20
Nuremberg	19
Frankfurt am Main	18
Houston	17
Montreal	17
Warsaw	17
Amsterdam	16
Brooklyn	15
Brno	14
San Diego	14
Shanghai	14
Buffalo	13
Kilburn	13
Manchester	13
Assago	12
Dong Ket	12
Munich	12
Da Nang	11
Hangzhou	11
Poplar	11
Abuja	10
Atlanta	10
Denver	10
Jacksonville	10
Vienna	10
Boston	9
Falkenstein	9
Lappeenranta	9
Salt Lake City	9
San Francisco	9
Belo Horizonte	8
Brasília	8
Cambridge	8
Düsseldorf	8
Paris	8
Stockholm	8
Woodbridge	8
Johannesburg	7
Phoenix	7
Portsmouth	7
Rio de Janeiro	7
Varese	7
Wilmington	7
Aldeatejada	6
Ankara	6
Bologna	6
Cairo	6
Goiânia	6
Hounslow	6
New Bedfont	6
Ninh Bình	6
Tianjin	6
Acton	5
Amman	5
Bogotá	5
Can Tho	5
Chiswick	5
Dalian	5
Damascus	5
Elk Grove Village	5
Genoa	5
New Delhi	5
Tashkent	5
Toronto	5
Turku	5
Zhengzhou	5
Totale	6.883

Salva come PNG Salva come JPEG

Nome	#
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections	194
Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis	141
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)	133
Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality	128
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study	124
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study	120
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant	120
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience	118
CARVs, CLAD, and CMV: A Call for Heightened Awareness in Lung Transplant Recipients	117
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains	114
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review	112
A look at clinical trial design for new antimicrobials for the adult population	111
How to manage KPC infections	109
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study	106
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination	105
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?	105
Clinical efficacy of beta-lactam/beta-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)	105
Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study	102
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study	100
SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients	100
10years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation	100
Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey	98
Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance	97
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients	94
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa	93
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study	92
Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe	91
'Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients': authors' response	91
Perioperative Antibiotic Stewardship in the Organ Transplant Setting	88
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study	87
Risk scores and surgery for infective endocarditis: in search of a good predictive score	86
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery	85
Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: active surveillance enhances recipient safety	84
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study	84
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature	83
Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study	83
Saprochaete capitata aortitis in an immunocomopetent patient after myocardial revascularization	82
Neuroinvasive West Nile Infection with an Unusual Clinical Presentation: A Single-Center Case Series	81
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance	81
Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients	81
Prevention and Treatment of Respiratory Virus Infection	79
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study	78
Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge	78
Mycobacterium chimaera infection after cardiac surgery: Catastrophic effects of delayed diagnosis	77
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis	77
The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014	77
The management of multidrug-resistant Enterobacteriaceae	77
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa	77
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	76
Environmental variables associated with an increased risk of invasive aspergillosis	76
Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia	76
Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients	76
Fungal Endogenous Endophthalmitis Secondary to Magnusiomyces capitatus	76
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study	76
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam	75
The current treatment landscape: candidiasis	75
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections	75
Cystic dystrophy of the pancreas in patient with only one previous cyst	75
Prognostic Role of Malnutrition Diagnosed by Bioelectrical Impedance Vector Analysis in Older Adults Hospitalized with COVID-19 Pneumonia: A Prospective Study	75
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)	74
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia	74
Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors	74
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam	74
Effects of Immunocompromise and Comorbidities on Pneumococcal Serotypes Causing Invasive Respiratory Infection in Adults: Implications for Vaccine Strategies	74
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?	74
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis	73
COVID-19 positive donor for solid organ transplantation	73
What Kind of Interventions Were Perceived as Effective Against Coronavirus-19 in Nursing Homes in Italy? A Descriptive Qualitative Study	73
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis	73
Community-acquired pneumonia: is less more?	72
Salvage heart transplantation for Mycoplasma hominis prosthetic valve endocarditis: A case report and review of the literature	72
The burden of severe cases of Influenza disease: the Friuli Venezia Giulia Region experience	72
Multidrug-resistant Gram-negative bacteria-resistant infections: epidemiology, clinical issues and therapeutic options	72
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project	72
When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections	72
Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients	71
The safety of treatment options for acute bacterial skin and skin structure infections	71
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality	71
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia	70
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery	70
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country	70
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe	70
Recent concepts in fungal involvement in skin and soft tissue infections	69
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria	69
Italian epidemiology of Gram negative bloodstream infections over 4-year period	68
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection	68
Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient	67
The role of dalbavancin in skin and soft tissue infections	67
Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study	67
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy	67
New antibiotics for ventilator-associated pneumonia	67
Treatment of Infections Due to MDR Gram-Negative Bacteria	66
Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19	66
Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control Study	65
Estimated burden of fungal infections in Italy	65
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?	64
Filamentous fungal infections in immunosuppressed patients: prophylaxis and treatment	63
Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction	63
Daptomycin-containing regimens for treatment of Gram-positive endocarditis	62
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia	61
Totale	8.421

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	60.130
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	60.130

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	26	0	0	0	0	0	0	0	0	0	4	4	18
2021/2022	219	0	1	0	1	2	2	0	0	112	22	2	77
2022/2023	628	48	3	7	75	44	209	2	85	94	29	16	16
2023/2024	2.797	386	446	421	537	610	200	35	47	45	17	11	42
2024/2025	1.780	7	39	323	81	59	100	89	74	236	154	153	465
2025/2026	4.099	283	330	399	536	322	187	1.044	275	482	241	0	0
Totale													9.603